Administrative Core
行政核心
基本信息
- 批准号:10254245
- 负责人:
- 金额:$ 13.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-25 至 2022-09-22
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAdvocacyAdvocateAfrican AmericanAmericasAppointmentAreaAvena sativaBusinessesClinicalClinical ResearchCollaborationsCollectionCommunicationCommunitiesConflict of InterestDataDiagnosisEffectivenessEnsureEthnic groupEvaluationFacultyFamilyFosteringFoundationsFundingGoalsGrantHealthHealth ProfessionalHuman ResourcesIncidenceIndividualInfrastructureInvestigationIslandKnowledgeLeadLeadershipLupusMeasuresMedicalMentorsMissionMonitorMorbidity - disease rateNational Institute of Arthritis and Musculoskeletal and Skin DiseasesOutcomeOutputPatientsPerformancePilot ProjectsPreventionPrevention strategyProblem SolvingProductivityRaceReportingResearchResearch ActivityResearch InstituteResearch PersonnelResource SharingResourcesRheumatismRiskSamplingScientistSclerodermaSeaServicesSeveritiesSilverSouth CarolinaSystemic Lupus ErythematosusSystemic SclerodermaTimeTranslational ResearchTravelUnderrepresented MinorityUnited StatesUniversitiesUpdateclinical careclinical centerdesignexperiencefollow-uphealth disparityimprovedinnovationmeetingsmemberminority healthminority investigatoroperationoutreachprogramsresearch studyshared databasetoolweb site
项目摘要
PROJECT SUMMARY
The Administrative Core of the Core Center for Clinical Research (CCCR) for Improving Minority Health in
Rheumatic Diseases (IMHRD, pronounced IaMHeaRD) at the Medical University of South Carolina will provide
leadership and management for the center and implement a pilot projects program that will be funded entirely
with institutional commitments. The mission of this CCCR is to advance knowledge with respect to the clinical
care and health outcomes of African Americans who have, or who are at risk of developing, systemic lupus
erythematosus, scleroderma and other debilitating rheumatic diseases. The overarching goals of the
Administrative Core are to: (a) ensure the quality, validity, accessibility and applicability of the tools, services,
samples, data and other output of the CCCR cores, (b) foster interactions among basic, translational and clinical
scientists at MUSC and beyond to focus effectively on advancing prevention, diagnosis and treatment of
rheumatic diseases, and (c) facilitate appropriate dissemination of research results and resources. To achieve
these goals, we will pursue the following specific aims: 1. Provide leadership for the CCCR; 2. Coordinate and
manage CCCR organizational, operational and financial functions and evaluative activities; 3. Leverage
institutional infrastructure resources; 4. Develop and manage a multi-year Evaluation Plan; 5. Strengthen and
expand robust, effective communication, dissemination and outreach activities, fostering mutually productive
interactions among members of health professional, scientific and citizen communities; and 6. Provide a
competitive Pilot Projects Program. This core will be directed by Gary Gilkeson, MD, with assistance from two
Associate Directors, Jim Oates, MD, and Richard Silver, MD, an Executive Committee that includes core leaders
and Research Community representatives, an Internal Advisory Committee that includes institutional
stakeholders and patient advocates, and an External Advisory Committee that includes experts in the field with
experience leading other NIAMS centers. The Administrative Core staff will provide administrative support for
the center, administering and monitoring the finances, coordinating meetings and action items, and interfacing
with NIAMS staff and institutional personnel. The Administrative Core also will support educational and
dissemination activities to enhance the visibility and impact of the center within MUSC and the local community
and provide a forum for communicating and exchanging research ideas. The Administrative Core will nurture a
vibrant, interactive program of clinical and translational research that will advance our knowledge and resources
for improving the prevention, diagnosis, treatment and health outcomes for rheumatic diseases, notably systemic
lupus erythematosus (SLE) and systemic sclerosis (SSc), which occur significantly more often and with greater
severity in African Americans than in other racial and ethnic groups in the United States.
项目摘要
临床研究核心中心(CCCR)的行政核心,以改善少数民族健康,
南卡罗来纳州医科大学的风湿性疾病(IMHRD,发音为IaMHeaRD)将提供
领导和管理的中心,并实施试点项目计划,将完全资助
机构的承诺。本CCCR的使命是推进临床方面的知识
患有系统性狼疮或有发生系统性狼疮风险的非裔美国人的护理和健康结果
红斑、硬皮病和其他使人衰弱的风湿性疾病。的总体目标
行政核心是:(a)确保工具、服务的质量、有效性、可获得性和适用性,
CCCR核心的样本、数据和其他输出,(B)促进基础、转化和临床之间的互动
科学家在MUSC和超越有效地专注于推进预防,诊断和治疗
(c)促进研究成果和资源的适当传播。实现
为实现这些目标,我们将努力实现以下具体目标:为CCCR提供领导; 2。协调和
管理CCCR的组织、业务和财务职能以及评估活动; 3.杠杆
机构基础设施资源; 4.制定和管理多年评估计划; 5.加强和
扩大强有力、有效的沟通、传播和外联活动,
卫生专业人员、科学界和公民社区成员之间的互动; 6.提供
有竞争力的试点项目。该核心将由医学博士加里吉尔克森指导,并由两名
副董事,吉姆奥茨,医学博士,和理查德银,医学博士,执行委员会,其中包括核心领导人
和研究界代表,一个内部咨询委员会,其中包括机构
利益相关者和患者倡导者,以及包括该领域专家在内的外部咨询委员会,
领导其他NIAMS中心的经验。行政核心工作人员将提供行政支助,
该中心,管理和监督财务,协调会议和行动项目,并接口
与NIAMS的工作人员和机构人员。行政核心还将支持教育和
开展宣传活动,提高中心在MUSC和当地社区的知名度和影响力
并提供一个交流和交换研究思想的论坛。行政核心将培育一个
充满活力的,互动的临床和转化研究计划,将促进我们的知识和资源
改善风湿性疾病的预防、诊断、治疗和健康结果,特别是全身性
红斑狼疮(SLE)和系统性硬化症(SSc),发生率明显更高,
严重程度在非洲裔美国人比其他种族和族裔群体在美国。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gary S Gilkeson其他文献
Podocytes: A Potential Source of Nitric Oxide Production in Murine Lupus Nephritis
- DOI:
10.1016/j.freeradbiomed.2010.10.406 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Ahmad K Mashmoushi;Ann F Hofbauer;Gary S Gilkeson;Jim C Oates - 通讯作者:
Jim C Oates
Role of Nitric Oxide in Podocyte Physiology in Lupus Nephritis
- DOI:
10.1016/j.freeradbiomed.2012.10.228 - 发表时间:
2012-11-01 - 期刊:
- 影响因子:
- 作者:
Ahmad K Mashmoushi;Ann F Hofbauer;Gary S Gilkeson;Jim C Oates - 通讯作者:
Jim C Oates
Human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages
- DOI:
10.1136/annrheumdis-2021-220793. - 发表时间:
2022 - 期刊:
- 影响因子:
- 作者:
Linyu Geng;Jian Zhao;Yun Deng;Ivan Molano;Xue Xu;Lingxiao Xu;Phillip Ruiz;Quanzhen Li;Xuebing Feng;Miaojia Zhang;Wenfeng Tan;Diane L Kamen;San-Cheol Bae;Gary S Gilkeson;Lingyun Sun;Betty P Tsao - 通讯作者:
Betty P Tsao
PSS61 - Nitric Oxide Modulation of Redox-Modulated Cytokines in Lupus Nephritis
- DOI:
10.1016/j.freeradbiomed.2013.10.476 - 发表时间:
2013-11-01 - 期刊:
- 影响因子:
- 作者:
Jim C Oates;Ahmad K Mashmoushi;Ann F Hofbauer;Gary S Gilkeson - 通讯作者:
Gary S Gilkeson
Human SLE variant emNCF1/em-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages
人类系统性红斑狼疮变异体 emNCF1/em-R90H 通过巨噬细胞吞噬缺陷导致的 Tfh2 反应增强促进肾脏损伤和小鼠狼疮
- DOI:
10.1136/annrheumdis-2021-220793 - 发表时间:
2022-02-01 - 期刊:
- 影响因子:20.600
- 作者:
Linyu Geng;Jian Zhao;Yun Deng;Ivan Molano;Xue Xu;Lingxiao Xu;Phillip Ruiz;Quanzhen Li;Xuebing Feng;Miaojia Zhang;Wenfeng Tan;Diane L Kamen;Sang-Cheol Bae;Gary S Gilkeson;Lingyun Sun;Betty P Tsao - 通讯作者:
Betty P Tsao
Gary S Gilkeson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gary S Gilkeson', 18)}}的其他基金
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
同种异体间充质干细胞治疗难治性狼疮的 II 期对照试验
- 批准号:
10827646 - 财政年份:2018
- 资助金额:
$ 13.43万 - 项目类别:
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
同种异体间充质干细胞治疗难治性狼疮的 II 期对照试验
- 批准号:
10356843 - 财政年份:2018
- 资助金额:
$ 13.43万 - 项目类别:
Role of Gut Microbial Translocation in Initiating Autoimmunity
肠道微生物易位在启动自身免疫中的作用
- 批准号:
10291780 - 财政年份:2014
- 资助金额:
$ 13.43万 - 项目类别:
Role of Gut Microbial Translocation in Initiating Autoimmunity
肠道微生物易位在启动自身免疫中的作用
- 批准号:
9564333 - 财政年份:2014
- 资助金额:
$ 13.43万 - 项目类别:
Mesenchymal Stem Cell Therapy for Active Systemic Lupus Erythematosus
间充质干细胞治疗活动性系统性红斑狼疮
- 批准号:
8791443 - 财政年份:2014
- 资助金额:
$ 13.43万 - 项目类别:
Sex Differences in Gut Permeability; Impact on Autoimmunity
肠道渗透性的性别差异;
- 批准号:
8958705 - 财政年份:2014
- 资助金额:
$ 13.43万 - 项目类别:
Sex Differences in Gut Permeability; Impact on Autoimmunity
肠道渗透性的性别差异;
- 批准号:
8820340 - 财政年份:2014
- 资助金额:
$ 13.43万 - 项目类别:
相似海外基金
Developing a network for mutual learning on the potential of creative arts for mental health advocacy and activism in Ghana and Indonesia
建立一个网络,以相互学习创意艺术在加纳和印度尼西亚促进心理健康倡导和行动的潜力
- 批准号:
AH/X009637/1 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Research Grant
Engaging adolescents for sexual and reproductive health and rights and family planning advocacy in Pakistan.
让巴基斯坦青少年参与性健康和生殖健康及权利以及计划生育宣传。
- 批准号:
490127 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Operating Grants
Transfer Advocacy Groups: Transforming Culture to Support Community College Transfer Students of Color in Undergraduate Physics
转学倡导团体:转变文化以支持社区学院本科物理有色人种转学生
- 批准号:
2224295 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Continuing Grant
Developing a cultural adaptation framework for youth mental health education and advocacy initiatives at Jack.org
Jack.org 为青少年心理健康教育和宣传活动制定文化适应框架
- 批准号:
484618 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Fellowship Programs
Protection without Advocacy: Japan's Failure to Support Persons with Mental Disabilities in the community
没有倡导的保护:日本未能支持社区中的精神残疾人
- 批准号:
23K01937 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
- 批准号:
10683644 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Lupus and health information: Evidence-informed advocacy in action
狼疮和健康信息:循证宣传在行动
- 批准号:
485670 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Miscellaneous Programs
Initiating Meaningful Partnerships for Advocacy and Collaborative Training: The IMPACT initiative
发起有意义的倡导和协作培训伙伴关系:IMPACT 倡议
- 批准号:
487847 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Miscellaneous Programs
Creating advocacy and tech to make secondhand first choice.
创造宣传和技术,让二手货成为首选。
- 批准号:
10064859 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Collaborative R&D
Advocacy Strategies supporting Social Determinants of Health: Paving the Path to Community Reintegration and Recovery
支持健康问题社会决定因素的倡导策略:为社区重新融入和恢复铺平道路
- 批准号:
480718 - 财政年份:2023
- 资助金额:
$ 13.43万 - 项目类别:
Miscellaneous Programs